本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

梯瓦制药

19.31
-0.3200-1.63%
盘后19.340.0300+0.16%19:54 EDT
成交量:773.13万
成交额:1.49亿
市值:221.51亿
市盈率:-137.15
高:19.69
开:19.40
低:19.07
收:19.63
52周最高:22.80
52周最低:12.47
股本:11.47亿
流通股本:11.42亿
量比:0.94
换手率:0.68%
股息:- -
股息率:- -
每股收益(TTM):-0.1408
每股收益(LYR):-1.4492
净资产收益率:-2.42%
总资产收益率:5.37%
市净率:3.24
市盈率(LYR):-13.32

数据加载中...

2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/29

重要事件披露

Form 8-K - Current report
2024/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

重要事件披露

Form 8-K - Current report